2m 2m 2m 2m 2m 2m 2m
Eli Lilly & Co (LLY)
NYSE
$1,095.09-$6.99 (-0.63%)
Price as of Jun 23, 2026 12:08 PM EDT- $982.8BMarket Cap
- 44.02%1-Year Change
- Drug Manufacturers - GeneralIndustry
Eli Lilly & Co (LLY)
$1,095.09-$6.99 (-0.63%)
LLY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1,102.08 | ||
Change | +$3.51 (+0.32%) | ||
Open | $1,112.24 | ||
High | $1,119.45 | ||
Low | $1,093.15 | ||
Previous Close | $1,098.57 | ||
Volume | 3,015,041 | ||
30-Day Average Volume | 3,274,717 | ||
1-Week Change | -2.41% | ||
1-Month Change | 3.48% | ||
1-Year Change | 44.02% | ||
3-Year Change | 145.98% | ||
5-Year Change | 421.73% | ||
Fundamentals | |||
Shares Outstanding | 891.7M | ||
Total Assets | $116.6B | ||
Market Cap | $982.8B | ||
Enterprise Value | $1.0T | ||
Period: QTR TTM FY | |||
Revenue | $19.8B | ||
Net Income | $7.4B | ||
Free Cash Flow | $5.3B | ||
EBIT | $8.8B | ||
EBITDA | $9.4B | ||
Net Working Capital | $18.2B | ||
EPS | $8.26 | ||
Enterprise Value/EBITDA | 109 | ||
Enterprise Value/Revenue | 52 | ||
P/B | 32 | ||
P/E | 133 | ||
PEG | 11 | ||
Price/Free Cash Flow | 184 | ||
Price/Operating Cash Flow | 184 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.63% | ||
Trailing Annual Dividend Yield | 0.59% | ||
Ex-Dividend Date | 05/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield